Clinical Causes of Inflammation in Peritoneal Dialysis Patients

被引：35
作者：
Cho, Yeoungjee [1 ,2 ]
Hawley, Carmel M. [1 ,2 ]
Johnson, David W. [1 ,2 ,3 ]
机构：
[1] Univ Queensland, Princess Alexandra Hosp, Dept Renal Med, Ipswich Rd,Woolloongabba, Brisbane, Qld 4102, Australia
[2] Translat Res Inst, Brisbane, Qld 4102, Australia
[3] Princess Alexandra Hosp, Dept Nephrol, Brisbane, Qld 4102, Australia
来源：
INTERNATIONAL JOURNAL OF NEPHROLOGY | 2014年 / 2014卷
关键词：
D O I：
10.1155/2014/909373
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Inflammation at both systemic and local intraperitoneal levels commonly affects peritoneal dialysis (PD) patients. Interest in inflammatory markers as targets of therapeutic intervention has been considerable as they are recognised as predictors of poor clinical outcomes. However, prior to embarking on strategies to reduce inflammatory burden, it is of paramount importance to define the underlying processes that drive the chronic active inflammatory status. The present review aims to comprehensively describe clinical causes of inflammation in PD patients to which potential future strategies may be targeted.
引用
收藏
页数：9
相关论文
共 92 条
  • [1] PERITONEAL MORPHOLOGY AFTER LONG-TERM PERITONEAL DIALYSIS WITH BIOCOMPATIBLE FLUID: RECENT CLINICAL PRACTICE IN JAPAN
    Ayuzawa, Nobuhiro
    Ishibashi, Yoshitaka
    Takazawa, Yutaka
    Kume, Haruki
    Fujita, Toshiro
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 2012, 32 (02): : 159 - 167
  • [2] Bargman JM, 2001, J AM SOC NEPHROL, V12, P2158, DOI 10.1681/ASN.V12102158
  • [3] The role of inflammation and infection in coronary artery disease
    Becker, AE
    de Boer, OJ
    van der Wal, AC
    [J]. ANNUAL REVIEW OF MEDICINE, 2001, 52 : 289 - 297
  • [4] BEMELMANS MHA, 1993, J IMMUNOL, V150, P2007
  • [5] Is TWEAK a biomarker for autoimmune/chronic inflammatory diseases?
    Bertin, Daniel
    Stephan, Delphine
    Khrestchatisky, Michel
    Desplat-Jego, Sophie
    [J]. FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [6] C-reactive protein
    Black, S
    Kushner, I
    Samols, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (47) : 48487 - 48490
  • [7] Integrated end-stage renal disease care: the role of peritoneal dialysis
    Blake, PG
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 : 61 - 66
  • [8] The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels
    Borazan, A
    Ustün, H
    Ustundag, Y
    Aydemir, S
    Bayraktaroglu, T
    Sert, M
    Yilmaz, A
    [J]. MEDIATORS OF INFLAMMATION, 2004, 13 (03) : 201 - 204
  • [9] Recent Peritonitis Associates with Mortality among Patients Treated with Peritoneal Dialysis
    Boudville, Neil
    Kemp, Anna
    Clayton, Philip
    Lim, Wai
    Badve, Sunil V.
    Hawley, Carmel M.
    McDonald, Stephen P.
    Wiggins, Kathryn J.
    Bannister, Kym M.
    Brown, Fiona G.
    Johnson, David W.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (08): : 1398 - 1405
  • [10] Brown F., 2012, ANZDATA 2012 ANN REP
12345678910